Metagenomi Therapeutics, Inc. (MGX)
0.9326
-0.09
(-8.57%)
USD |
NASDAQ |
Oct 13, 13:16
Metagenomi Therapeutics Market Cap : 35.23M for Oct. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 12, 2026 | 38.53M |
| October 09, 2026 | 37.78M |
| October 08, 2026 | 37.52M |
| October 07, 2026 | 37.20M |
| October 06, 2026 | 38.91M |
| October 05, 2026 | 39.29M |
| October 02, 2026 | 38.53M |
| October 01, 2026 | 41.74M |
| September 30, 2026 | 40.04M |
| September 29, 2026 | 42.69M |
| September 28, 2026 | 43.07M |
| September 25, 2026 | 43.44M |
| September 24, 2026 | 43.44M |
| September 23, 2026 | 42.69M |
| September 22, 2026 | 43.07M |
| September 21, 2026 | 42.31M |
| September 18, 2026 | 41.55M |
| September 17, 2026 | 42.69M |
| September 16, 2026 | 43.44M |
| September 15, 2026 | 43.82M |
| September 14, 2026 | 44.95M |
| September 11, 2026 | 43.82M |
| September 10, 2026 | 43.82M |
| September 09, 2026 | 43.44M |
| September 08, 2026 | 43.82M |
| Date | Value |
|---|---|
| September 04, 2026 | 44.20M |
| September 03, 2026 | 43.82M |
| September 02, 2026 | 43.82M |
| September 01, 2026 | 44.20M |
| August 31, 2026 | 44.58M |
| August 28, 2026 | 44.95M |
| August 27, 2026 | 45.71M |
| August 26, 2026 | 46.09M |
| August 25, 2026 | 45.71M |
| August 24, 2026 | 45.71M |
| August 21, 2026 | 46.47M |
| August 20, 2026 | 45.33M |
| August 19, 2026 | 46.84M |
| August 18, 2026 | 45.71M |
| August 17, 2026 | 46.09M |
| August 14, 2026 | 46.47M |
| August 13, 2026 | 46.47M |
| August 12, 2026 | 46.09M |
| August 11, 2026 | 45.71M |
| August 10, 2026 | 46.47M |
| August 07, 2026 | 46.47M |
| August 06, 2026 | 46.84M |
| August 05, 2026 | 45.74M |
| August 04, 2026 | 45.55M |
| August 03, 2026 | 45.55M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.279B |
| Oncolytics Biotech, Inc. | 58.58M |
| Sangamo Therapeutics, Inc. | 62.14M |
| Sarepta Therapeutics, Inc. | 1.755B |
| Anixa Biosciences, Inc. | 94.42M |
Market Cap Related Metrics
| PS Ratio | 2.582 |
| PEG Ratio | -0.0628 |
| Price to Book Value | 0.3130 |
| Price | 0.9326 |
| Earnings Yield | -266.8% |
| PEGY Ratio | -0.0628 |